Clinical Trial Update: Add-on to Cognitive, Event-Related Potentials (ERP) and Electroencephalogram (EEG) Asymmetry in Affective Disorders [Phase 4]

View source ↗

Summary

Phase 4 trial investigating add-on ERP/EEG asymmetry in depressive illness was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Depressive Illness

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Depressive Illness | Phase 4 | Status: WITHDRAWN